Nuveen LLC Takes Position in Cardinal Health, Inc. (NYSE:CAH)

Key Points

• Nuveen LLC has acquired 769,872 shares of Cardinal Health, Inc. for approximately $106 million, increasing its stake to 0.32% as of the latest SEC filing.
• Cardinal Health's stock recently opened at $146.51 and has seen a fifty-two week low of $100.80 and a high of $168.44, with a market capitalization of $34.97 billion.
• Analysts have given Cardinal Health a consensus rating of "Moderate Buy", with target prices varying from $150 to $186, indicating expectations of growth in the company's earnings.

Nuveen LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 769,872 shares of the company's stock, valued at approximately $106,065,000. Nuveen LLC owned 0.32% of Cardinal Health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health in the first quarter worth approximately $26,000. Bellwether Advisors LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth $32,000. Tompkins Financial Corp grew its stake in shares of Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after buying an additional 128 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new position in shares of Cardinal Health during the 4th quarter worth about $36,000. Finally, GW&K Investment Management LLC boosted its stake in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after purchasing an additional 144 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of research analyst reports. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a report on Tuesday. Bank of America upped their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Wall Street Zen lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Robert W. Baird increased their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday. Finally, Evercore ISI decreased their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $163.20.

Cardinal Health Price Performance

Shares of NYSE CAH traded up $2.26 during trading hours on Thursday, reaching $150.38. The stock had a trading volume of 2,787,266 shares, compared to its average volume of 2,274,720. The business's fifty day moving average is $159.73 and its two-hundred day moving average is $144.34. The company has a market cap of $35.91 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.44 and a beta of 0.67. Cardinal Health, Inc. has a twelve month low of $105.01 and a twelve month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%. The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 earnings per share. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.